Reporting Bias in Randomized Controlled Trials of Homeopathy: A Critical Assessment and Re‐Analysis of Published Work
Journal of Evaluation in Clinical Practice · 2026-06 · 32 (4)
DOI: 10.1111/jep.70458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Evaluation in Clinical Practice, online erschienen am 26.05.2026. Verfasst von Angelina J Mosley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Homeopathy Research Institute, International House, London, UK. Hauptthemen laut MEDLINE: Homeopathy, Randomized Controlled Trials as Topic, Publication Bias. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Homeopathy Research Institute.
Abstract (Originalsprache)
Aim
Reporting bias is widespread in clinical trials, yet a 2022 assessment of reporting bias specifically in homeopathy claimed to show ‘ a concerning lack of scientific and ethical standards .’ If true, decisive action is needed. The aim of this study was thus to assess the reliability of these published claims.
Methods
Critical assessment of the 2022 published data ( N = 231 studies) was performed through in‐depth literature/trial registry searching and systematic data extraction. Substantial inaccuracies were identified and corrected. Reporting bias in homeopathy was then re‐analyzed ( N = 181 studies) emphasizing trial registration, publication rates and primary outcome change.
Results
Re‐analysis of the corrected data showed that 93% of registered homeopathy trials are published; 60% of published trials are registered; 64% of registered trials were registered before trial completion; and 11% of prospectively registered and published trials had a primary outcome change. Compared to the published 2022 values (62%, 48%, 50% and 25% respectively), reporting bias in homeopathy is less common than claimed. Furthermore, 88% of homeopathy trials mentioned ethical approval, and 70% of journals publishing homeopathy trials comply with the International Committee of Medical Journal Editors’ recommendations.
Conclusion
This re‐analysis shows that levels of reporting bias in homeopathy trials are at least comparable to those in the wider medical literature where half of registered trials remain unpublished and primary outcome change occurs in ~30%. Researchers in all medical disciplines, including homeopathy, should continue to strive towards the highest level of research standards, following international recommendations for registration and publication of all trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Homeopathy Research Institute, International House, London, UK.
ORCID-Profile: Angelina J Mosley, E Rachel Roberts
Förderung
- Homeopathy Research Institute
Zitieren
APA
Mosley, A. J., & Rachel Roberts, E. (2026). Reporting Bias in Randomized Controlled Trials of Homeopathy: A Critical Assessment and Re‐Analysis of Published Work. Journal of Evaluation in Clinical Practice, 32(4). https://doi.org/10.1111/jep.70458
Vancouver
Mosley AJ, Rachel Roberts E. Reporting Bias in Randomized Controlled Trials of Homeopathy: A Critical Assessment and Re‐Analysis of Published Work. Journal of Evaluation in Clinical Practice. 2026;32(4). doi:10.1111/jep.70458
BibTeX
@article{Mosley2026,
author = {Mosley, Angelina J and Rachel Roberts, E},
title = {Reporting Bias in Randomized Controlled Trials of Homeopathy: A Critical Assessment and Re‐Analysis of Published Work},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
volume = {32},
number = {4},
doi = {10.1111/jep.70458}
}
EUVIMED